ANI PHARMACEUTICALS INC's ticker is ANIP and the CUSIP is 00182C103. A total of 186 filers reported holding ANI PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 1.08 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,393,440 | +7.9% | 24,000 | 0.0% | 0.50% | +13.7% |
| Q2 2023 | $1,291,920 | +35.5% | 24,000 | 0.0% | 0.44% | +33.3% |
| Q1 2023 | $953,280 | -1.3% | 24,000 | 0.0% | 0.33% | -14.6% |
| Q4 2022 | $965,520 | +35.6% | 24,000 | 0.0% | 0.39% | +39.8% |
| Q3 2022 | $712,000 | 0.0% | 24,000 | 0.0% | 0.28% | 0.0% |
| Q2 2022 | $712,000 | +5.5% | 24,000 | 0.0% | 0.28% | +18.7% |
| Q1 2022 | $675,000 | -22.9% | 24,000 | +26.3% | 0.24% | -16.4% |
| Q4 2021 | $876,000 | +40.4% | 19,000 | 0.0% | 0.28% | +38.4% |
| Q3 2021 | $624,000 | -6.2% | 19,000 | 0.0% | 0.20% | -8.1% |
| Q2 2021 | $665,000 | -3.2% | 19,000 | 0.0% | 0.22% | -9.8% |
| Q1 2021 | $687,000 | +57.6% | 19,000 | +26.7% | 0.24% | +28.9% |
| Q4 2020 | $436,000 | +54.6% | 15,000 | +50.0% | 0.19% | +36.7% |
| Q3 2020 | $282,000 | – | 10,000 | – | 0.14% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| FIRST WILSHIRE SECURITIES MANAGEMENT INC | 328,494 | $15,137,000 | 4.72% |
| TANG CAPITAL MANAGEMENT LLC | 300,000 | $13,824,000 | 2.78% |
| Mesirow Financial Investment Management, Inc. | 12,277 | $566,000 | 1.63% |
| Parkman Healthcare Partners LLC | 137,226 | $6,323,000 | 1.40% |
| Global Alpha Capital Management Ltd. | 284,831 | $13,125,000 | 1.27% |
| Stonepine Capital Management, LLC | 52,290 | $2,410,000 | 1.11% |
| 1492 Capital Management LLC | 43,611 | $2,010,000 | 0.99% |
| MARATHON CAPITAL MANAGEMENT | 74,770 | $3,445,000 | 0.81% |
| Walthausen & Co., LLC | 61,456 | $2,832,000 | 0.74% |
| Rubric Capital Management LP | 307,557 | $14,172,000 | 0.67% |